gTLD	Full Legal Name	E-mail suffix	Detail
.cancerresearch	Australian Cancer Research Foundation	acrf.com.au	View

INTRODUCTION

All domain name registrations in the .cancerresearch TLD will be registered to and maintained by ACRF for its own exclusive use. ACRF will not distribute or transfer control or use of any registrations in the .cancerresearch TLD to any third party that is not an Affiliate, as that term is defined in clause 2.9(c) of the Registry Agreement. As such, ACRF will maintain complete control over .cancerresearch domain name registrations, as facilitated by the imposition of eligibility restrictions and internal policies and processes. ACRF has interpreted this question broadly and prepared this response taking into consideration social costs and other negative consequences facing consumers and Internet users who will access content through the .cancerresearch TLD; likewise, these are considered eliminated or minimised by the manner in which ACRF will operate the .cancerresearch TLD.

METHOD OF RESOLVING MULTIPLE APPLICATIONS

Multiple applications are not anticipated in the .cancerresearch TLD, as domain name registrations will be for controlled by ACRF for its exclusive use in the interests of the ACRF brand. Registrations will not be made commercially available and eligibility to register domain names will be limited to specifically authorised individuals under ACRF’s control. Thus, there are no competing interests and or opportunities for competing applications to be made. The decision-making authority as to which domain names will be registered and for which purposes will be not vested in a single individual; this will be addressed through internal processes regarding domain name registration, requiring approvals within established reporting lines and the use of usernames and passwords to register domain names. Compliance with these processes will ensure that multiple applications for the same name are not made.

COST BENEFITS TO REGISTRANTS

Registrations will not be commercially available in the .cancerresearch TLD; cost benefits to registrants are therefore not applicable to the TLD.

CONTRACTUAL COMMITMENTS TO REGISTRANTS

Registrations will not be commercially available in the .cancerresearch TLD; contractual commitments regarding price escalation are therefore also not applicable to the TLD.

OTHER OPERATING RULES WHICH ELIMINATE OR MINIMISE SOCIAL COSTS

By imposing strict eligibility restrictions and internal processes regarding domain name registration and restricting the .cancerresearch TLD to uses that clearly support its mission⁄purpose and thus the ACRF business, it is anticipated that vulnerabilities to the registrant and the Internet public who access content through the .cancerresearch TLD can be eliminated. This will be safeguarded through internal policies and procedures which ensure that registrations are made by authorised representatives of ACRF using established reporting lines. Further, abusive registrations and use of registrations will be prevented by having in place and enforcing a robust anti-abuse policy; this policy is described in detail in the response to Question 28.

gTLD	Full Legal Name	E-mail suffix	Detail
.iinet	Connect West Pty. Ltd.	staff.iinet.net.au	View

INTRODUCTION

Connect West Pty Ltd (Connect West) intends to request an exemption from clause 1b of the Registry Operator Code of Conduct (Specification 9) pursuant to clause 6 of the Code of Conduct to enable it to register domain names in its own right in this TLD. Registrations will not be made commercially available; all domain name registrations in the TLD will be registered to and maintained by Connect West for its own exclusive use. Connect West will not sell, distribute or transfer control or use of any registration in the TLD to any third party that is not an Affiliate, as that term is defined in clause 2.9(c) of the Registry Agreement.

Connect West has interpreted this question broadly and prepared this response taking into consideration social costs and other negative consequences facing the consumers and other Internet users who will access content through the .iinet TLD; these are likewise considered eliminated or minimised by the manner in which Connect West will operate the .iinet TLD.

METHOD OF RESOLVING MULTIPLE APPLICATIONS

Multiple applications are not anticipated in the .iinet TLD, as domain name registrations will be for Connect West’s exclusive use and in the interests of its iiNet business. Domain names will not be made commercially available; eligibility to register domain names will be limited to specifically authorised individuals under Connect West’s control. Thus, there are no competing interests or opportunities for competing applications to be made. The decision-making authority as to which domain names will be registered and for which purposes will be vested in specifically designated individuals; this will be enforced through internal processes regarding domain name registration, requiring approvals within established reporting lines and the use of usernames and passwords to register domain names. Compliance with these processes will ensure that multiple applications for the same name are not made.

COST BENEFITS TO REGISTRANTS

Registrations will not be commercially available in the .iinet TLD; cost benefits to registrants are therefore not applicable to this TLD.

CONTRACTUAL COMMITMENTS TO REGISTRANTS

Registrations will not be commercially available in the .iinet TLD; contractual commitments regarding price escalation are therefore also not applicable to this TLD.

OTHER OPERATING RULES WHICH ELIMINATE OR MINIMISE SOCIAL COSTS

By imposing strict eligibility and use restrictions that ensure that registrations support the mission and purpose of the TLD and Connect West’s business, it is anticipated that vulnerabilities to the single registrant, domain name users and Internet users can be eliminated. Abusive registrations and use of registrations will be prevented by having in place and enforcing a robust anti-abuse policy; this policy is described in detail in the response to Question 28.